Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,960,337)	$ (2,349,862)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,507	220,954
Accrued interest on loan payable, deferred compensation and other	308,347	291,143
Stock-based compensation	481,565	348,503
Decrease in prepaid expenses	8,504	1,893
Increase in accounts payable and accrued expenses	133,171	29,135
Increase in deferred compensation	627,200	757,200
Net cash used in operating activities	(400,043)	(701,034)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(5,178)
Net cash used by investing activities		(5,178)
CASH FLOWS FROM FINANCING ACTIVITIES
Decrease in subscription receivable	7,500	13,125
Proceeds from sale of common stock	22,850
Proceeds from sale of units	249,628	208,000
Commissions on sale of units	(14,212)	(18,300)
Proceeds from promissory note receivable		35,000
Proceeds from exercise of warrants		184,689
Net cash provided by financing activities	265,766	422,514
Net decrease in cash	(134,277)	(283,698)
Cash at beginning of period	170,194	339,286
Cash at end of period	35,917	55,588
Supplemental disclosure of cash flow information:
Cash paid for interest
Non-cash investing and financing transactions:
Issuance of common stock to satisfy deferred compensation	140,502	176,717
Purchase of warrants for subscription receivable - affiliate	40,000
Subscription receivable		32,727
Note Receivable as Consideration for Warrants Exercise [Member]
Non-cash investing and financing transactions:
Exercise of warrants for promissory note receivable for shares		$ 105,000